Deutschland - Deutsch - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

adamed pharma s.a. (8115435) - rosuvastatin-hemicalcium; ezetimib - tablette - teil 1 - tablette; rosuvastatin-hemicalcium (30683) 10,4 milligramm; ezetimib (30225) 10 milligramm

Deutschland - Deutsch - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

adamed pharma s.a. (8115435) - rosuvastatin-hemicalcium; ezetimib - tablette - teil 1 - tablette; rosuvastatin-hemicalcium (30683) 20,8 milligramm; ezetimib (30225) 10 milligramm

Deutschland - Deutsch - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

adamed pharma s.a. (8115435) - rosuvastatin-hemicalcium; ezetimib - tablette - teil 1 - tablette; rosuvastatin-hemicalcium (30683) 5,2 milligramm; ezetimib (30225) 10 milligramm

Europäische Union - Deutsch - EMA (European Medicines Agency)

eli lilly nederland b.v. - abemaciclib - brustgeschwulste - antineoplastische mittel - early breast cancerverzenios in combination with endocrine therapy is indicated for the adjuvant treatment of adult patients with hormone receptor (hr) positive, human epidermal growth factor receptor 2 (her2) negative, node positive early breast cancer at high risk of recurrence (see section 5. in pre or perimenopausal women, aromatase inhibitor endocrine therapy should be combined with a luteinising hormone-releasing hormone (lhrh) agonist. advanced or metastatic breast cancerverzenios is indicated for the treatment of women with hormone receptor (hr) positive, human epidermal growth factor receptor 2 (her2) negative locally advanced or metastatic breast cancer in combination with an aromatase inhibitor or fulvestrant as initial endocrine-based therapy, or in women who have received prior endocrine therapy. in pre- or perimenopausal women, the endocrine therapy should be combined with a lhrh agonist.

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

viatris pharma gmbh - ibuprofenum - filmtabletten - ibuprofenum 200 mg, cellulosum microcristallinum, carmellosum natricum conexum, lactosum monohydricum 13.3 mg, silica colloidalis anhydrica, natrii laurilsulfas, magnesii stearas, Überzug: hypromellosum, talcum, e 171, pro compresso obducto corresp. natrium 0.414 mg. - antirheumatikum, antiphlogistikum - synthetika

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

viatris pharma gmbh - ibuprofenum - filmtabletten - ibuprofenum 400 mg, cellulosum microcristallinum, carmellosum natricum conexum, lactosum monohydricum 26.67 mg, silica colloidalis anhydrica, natrii laurilsulfas, magnesii stearas, Überzug: hypromellosum, talcum, e 171, pro compresso obducto corresp. natrium 0.828 mg. - antirheumatikum, antiphlogistikum - synthetika

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

viatris pharma gmbh - ibuprofenum - filmtabletten - ibuprofenum 600 mg, cellulosum microcristallinum, carmellosum natricum conexum, lactosum monohydricum 40 mg, silica colloidalis anhydrica, natrii laurilsulfas, magnesii stearas, Überzug: hypromellosum, talcum, e 171, pro compresso obducto corresp. natrium 1.242 mg. - antirheumatikum, antiphlogistikum - synthetika

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

viatris pharma gmbh - ibuprofenum - brausegranulat - ibuprofenum 600 mg, cellulosum microcristallinum, carmellosum natricum conexum, acidum malicum, povidonum k 29-32, natrii laurilsulfas, natrii hydrogenocarbonas, natrii carbonas, saccharinum natricum, saccharum 3.333 g, aromatica (orange), ad granulatum, pro charta corresp. natrium 196.827 mg. - antirheumatikum, antiphlogistikum - synthetika

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

eli lilly (suisse) sa - abemaciclibum - filmtabletten - abemaciclibum 50 mg, excipiens pro treiber obducto. - brustkrebs - synthetika

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

eli lilly (suisse) sa - abemaciclibum - filmtabletten - abemaciclibum 100 mg, excipiens pro treiber obducto. - brustkrebs - synthetika